PHI 73/23 Cost Recovery Implementation Statement for the National Joint Replacement Registry

Release of the Cost Recovery Implementation Statement for 2023-24

Date published:
PHI circular type:
Prescribed List announcement
Audience:
General public

The 2023-24 National Joint Replacement Registry (NJRR) Cost Recovery Implementation Statement (CRIS) is now available.

The CRIS provides information on how we manage cost recovery to provide Commonwealth funding to the Australian Orthopaedic Association (AOA) for the administration of the NJRR. It also includes financial forecast and detailed activities planned for the NJRR for each financial year between 2023 and 2027.

We consulted on the current CRIS in May 2023. The stakeholder feedback to this consultation is summarised in Attachment A of the NJRR CRIS, together with our response to the feedback.

The final CRIS reflects a 12-month extension of the 2019-20 funding agreement to manage the NJRR from 1 July 2023 to 30 June 2024 (for existing activities only). This extension to the funding agreement was agreed between the department and the AOA in September 2023. It also includes the financial outcomes for 2022-23.

Background

We update the CRIS twice a year:

  • By 30 June to report on the next financial year. This includes updating financial estimates and outcomes for cost recovered activities reported on an annual basis, in line with the Australian Government Cost Recovery Guidelines.
  • By 30 November to update the CRIS to report the financial outcomes of the preceding financial year.

If you have any questions regarding these updates, please email PLcostrecovery@Health.gov.au